In-Pharmatechnologist.com joins BASF and Dow at CPhI India 22-Nov-2012 By Gareth Macdonald in-Pharmatechnologist.com is in Mumbai this week for CPhI India to report news from BASF, Dow Wolff Cellulosics and Bend Research.
Johnson Matthey's API biz on the up whilst catalyst profits dip 22-Nov-2012 By Natalie Morrison Johnson Matthey saw an uptick in its API business thanks to demand for “higher margin” products.
FDA stresses importance of IRB role in new draft guidelines FDA stresses importance of IRB role in new draft guidelines 22-Nov-2012 By Gareth Macdonald The US FDA wants IRBs to remember it is their responsibility to check investigator qualifications, make sure sites are up to code and say if an IND is necessary for the proposed trial.
News from CPhI Single-use lets some Pharmas make own potent drugs but outsourcing demand still strong: Alkermes 22-Nov-2012 By Natalie Morrison Single-use technology will see more HP production brought in-house but contract manufacturers will still win-out, according to Alkermes.
SAFC to be renamed under Sigma-Aldrich business rejig 22-Nov-2012 Sigma-Aldrich has announced a plan to realign its business operations along regional and customer-focused lines.
News from CTI, AndersonBrecon and CIS – People on the move News from CTI, AndersonBrecon and CIS – People on the move 22-Nov-2012 By Natalie Morrison Outsourcing-Pharma.com presents its weekly round-up of the latest career climbers including news from CTI, AndersonBrecon and CIS.
Update - comments from EFPIA EC asks pharmas how long to add 'black symbol' to risky drugs 22-Nov-2012 By Gareth Macdonald The European Commission (EC) has asked the industry how long it will take to change labels of drugs marked for additional post-market monitoring.
